ID   G6PI_HUMAN              Reviewed;         558 AA.
AC   P06744; B4DG39; Q9BRD3; Q9BSK5; Q9UHE6;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 197.
DE   RecName: Full=Glucose-6-phosphate isomerase;
DE            Short=GPI;
DE            EC=5.3.1.9;
DE   AltName: Full=Autocrine motility factor;
DE            Short=AMF;
DE   AltName: Full=Neuroleukin;
DE            Short=NLK;
DE   AltName: Full=Phosphoglucose isomerase;
DE            Short=PGI;
DE   AltName: Full=Phosphohexose isomerase;
DE            Short=PHI;
DE   AltName: Full=Sperm antigen 36;
DE            Short=SA-36;
GN   Name=GPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Gurney M.E.;
RL   Submitted (MAR-1987) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=10727272; DOI=10.1095/biolreprod62.4.1016;
RA   Yakirevich E., Naot Y.;
RT   "Cloning of a glucose phosphate isomerase/neuroleukin-like sperm
RT   antigen involved in sperm agglutination.";
RL   Biol. Reprod. 62:1016-1023(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-208.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71.
RX   PubMed=2387591; DOI=10.1016/0888-7543(90)90212-D;
RA   Walker J.I.H., Faik P., Morgan M.J.;
RT   "Characterization of the 5' end of the gene for human glucose
RT   phosphate isomerase (GPI).";
RL   Genomics 7:638-643(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-12; 58-73; 97-104; 181-226; 424-438 AND 455-461,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [9]
RP   IDENTITY OF NEUROLEUKIN AS PGI.
RX   PubMed=3352745; DOI=10.1038/332455a0;
RA   Faik P., Walker J.I.H., Redmill A.A.M., Morgan M.J.;
RT   "Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3'
RT   sequences.";
RL   Nature 332:455-456(1988).
RN   [10]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-185.
RX   PubMed=11004567; DOI=10.1016/S0167-4838(00)00075-3;
RA   Haga A., Niinaka Y., Raz A.;
RT   "Phosphohexose isomerase/autocrine motility
RT   factor/neuroleukin/maturation factor is a multifunctional
RT   phosphoprotein.";
RL   Biochim. Biophys. Acta 1480:235-244(2000).
RN   [11]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=11437381; DOI=10.1006/bbrc.2001.5135;
RA   Funasaka T., Haga A., Raz A., Nagase H.;
RT   "Tumor autocrine motility factor is an angiogenic factor that
RT   stimulates endothelial cell motility.";
RL   Biochem. Biophys. Res. Commun. 285:118-128(2001).
RN   [12]
RP   SPECIES SPECIFICITY OF THE CYTOKINE FUNCTION.
RX   PubMed=12163179; DOI=10.1016/S0014-5793(02)03072-7;
RA   Amraei M., Nabi I.R.;
RT   "Species specificity of the cytokine function of phosphoglucose
RT   isomerase.";
RL   FEBS Lett. 525:151-155(2002).
RN   [13]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [14]
RP   PHOSPHORYLATION AT SER-185, AND MUTAGENESIS OF SER-185.
RX   PubMed=15637053; DOI=10.1074/jbc.M409457200;
RA   Yanagawa T., Funasaka T., Tsutsumi S., Raz T., Tanaka N., Raz A.;
RT   "Differential regulation of phosphoglucose isomerase/autocrine
RT   motility factor activities by protein kinase CK2 phosphorylation.";
RL   J. Biol. Chem. 280:10419-10426(2005).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-12 AND LYS-142, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   MALONYLATION AT LYS-454.
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107; THR-109 AND
RP   SER-455, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.62 ANGSTROMS), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=11371164; DOI=10.1006/jmbi.2001.4680;
RA   Read J., Pearce J., Li X., Muirhead H., Chirgwin J., Davies C.;
RT   "The crystal structure of human phosphoglucose isomerase at 1.6 A
RT   resolution: implications for catalytic mechanism, cytokine activity
RT   and haemolytic anaemia.";
RL   J. Mol. Biol. 309:447-463(2001).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) ALONE AND IN COMPLEX WITH
RP   INHIBITOR.
RX   PubMed=12054796; DOI=10.1016/S0022-2836(02)00186-9;
RA   Tanaka N., Haga A., Uemura H., Akiyama H., Funasaka T., Nagase H.,
RA   Raz A., Nakamura K.T.;
RT   "Inhibition mechanism of cytokine activity of human autocrine motility
RT   factor examined by crystal structure analyses and site-directed
RT   mutagenesis studies.";
RL   J. Mol. Biol. 318:985-997(2002).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) IN COMPLEX WITH INHIBITOR, AND
RP   ACTIVE SITE.
RX   PubMed=12777791; DOI=10.1107/S0907444903007352;
RA   Davies C., Muirhead H., Chirgwin J.;
RT   "The structure of human phosphoglucose isomerase complexed with a
RT   transition-state analogue.";
RL   Acta Crystallogr. D 59:1111-1113(2003).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=12573240; DOI=10.1016/S1570-9639(02)00464-8;
RA   Cordeiro A.T., Godoi P.H., Silva C.H., Garratt R.C., Oliva G.,
RA   Thiemann O.H.;
RT   "Crystal structure of human phosphoglucose isomerase and analysis of
RT   the initial catalytic steps.";
RL   Biochim. Biophys. Acta 1645:117-122(2003).
RN   [28]
RP   VARIANTS HA-GPID SER-159; HIS-347 AND THR-525.
RX   PubMed=8499925; DOI=10.1093/hmg/2.3.327;
RA   Walker J.I.H., Layton D.M., Bellingham A.J., Morgan M.J., Faik P.;
RT   "DNA sequence abnormalities in human glucose 6-phosphate isomerase
RT   deficiency.";
RL   Hum. Mol. Genet. 2:327-329(1993).
RN   [29]
RP   VARIANTS HA-GPID TRP-83; MET-224; HIS-273; LEU-278; CYS-347; PHE-487
RP   AND LYS-495.
RX   PubMed=7989588; DOI=10.1172/JCI117597;
RA   Xu W., Beutler E.;
RT   "The characterization of gene mutations for human glucose phosphate
RT   isomerase deficiency associated with chronic hemolytic anemia.";
RL   J. Clin. Invest. 94:2326-2329(1994).
RN   [30]
RP   VARIANTS HA-GPID MET-101; ILE-195; ARG-343 AND THR-525.
RX   PubMed=8822952;
RA   Baronciani L., Zanella A., Bianchi P., Zappa M., Alfinito F.,
RA   Iolascon A., Tannoia N., Beutler E., Sirchia G.;
RT   "Study of the molecular defects in glucose phosphate isomerase-
RT   deficient patients affected by chronic hemolytic anemia.";
RL   Blood 88:2306-2310(1996).
RN   [31]
RP   VARIANTS HA-GPID ILE-5; MET-224; ARG-343; ARG-375 AND ASN-539.
RX   PubMed=8822954;
RA   Kanno H., Fujii H., Hirono A., Ishida Y., Ohga S., Fukumoto Y.,
RA   Matsuzawa K., Ogawa S., Miwa S.;
RT   "Molecular analysis of glucose phosphate isomerase deficiency
RT   associated with hereditary hemolytic anemia.";
RL   Blood 88:2321-2325(1996).
RN   [32]
RP   VARIANTS HA-GPID GLY-75; PRO-300; CYS-347 AND HIS-472.
RX   PubMed=9446754; DOI=10.1006/bcmd.1997.0157;
RA   Beutler E., West C., Britton H.A., Harris J., Forman L.;
RT   "Glucosephosphate isomerase (GPI) deficiency mutations associated with
RT   hereditary nonspherocytic hemolytic anemia (HNSHA).";
RL   Blood Cells Mol. Dis. 23:402-409(1997).
RN   [33]
RP   VARIANTS HA-GPID PRO-20; PRO-339; ARG-389 AND VAL-517.
RX   PubMed=9856489; DOI=10.1007/s004390050849;
RA   Kugler W., Breme K., Laspe P., Muirhead H., Davies C., Winkler H.,
RA   Schroter W., Lakomek M.;
RT   "Molecular basis of neurological dysfunction coupled with haemolytic
RT   anaemia in human glucose-6-phosphate isomerase (GPI) deficiency.";
RL   Hum. Genet. 103:450-454(1998).
CC   -!- FUNCTION: Besides it's role as a glycolytic enzyme, mammalian GPI
CC       can function as a tumor-secreted cytokine and an angiogenic factor
CC       (AMF) that stimulates endothelial cell motility. GPI is also a
CC       neurotrophic factor (Neuroleukin) for spinal and sensory neurons.
CC       {ECO:0000269|PubMed:11004567, ECO:0000269|PubMed:11437381}.
CC   -!- CATALYTIC ACTIVITY: D-glucose 6-phosphate = D-fructose 6-
CC       phosphate.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate and glycerone phosphate from D-glucose: step 2/4.
CC   -!- SUBUNIT: Homodimer in the catalytically active form, monomer in
CC       the secreted form. {ECO:0000269|PubMed:11371164,
CC       ECO:0000269|PubMed:12054796, ECO:0000269|PubMed:12777791}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11437381}.
CC       Secreted {ECO:0000269|PubMed:11437381}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P06744-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06744-2; Sequence=VSP_043475, VSP_043476;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylation at Ser-185 by CK2 has been shown to decrease
CC       enzymatic activity and may contribute to secretion by a non-
CC       classical secretory pathway. {ECO:0000269|PubMed:11004567,
CC       ECO:0000269|PubMed:15637053}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- DISEASE: Hemolytic anemia, non-spherocytic, due to glucose
CC       phosphate isomerase deficiency (HA-GPID) [MIM:613470]: A form of
CC       anemia in which there is no abnormal hemoglobin or spherocytosis.
CC       It is caused by glucose phosphate isomerase deficiency.
CC       {ECO:0000269|PubMed:7989588, ECO:0000269|PubMed:8499925,
CC       ECO:0000269|PubMed:8822952, ECO:0000269|PubMed:8822954,
CC       ECO:0000269|PubMed:9446754, ECO:0000269|PubMed:9856489}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the GPI family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=GPI";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Phosphoglucose isomerase entry;
CC       URL="https://en.wikipedia.org/wiki/Phosphoglucose_isomerase";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gpi/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K03515; AAA36368.1; -; mRNA.
DR   EMBL; AF187554; AAF22645.1; -; mRNA.
DR   EMBL; AY324386; AAP72966.1; -; Genomic_DNA.
DR   EMBL; AK294396; BAG57650.1; -; mRNA.
DR   EMBL; AC010504; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004982; AAH04982.1; -; mRNA.
DR   EMBL; AH002710; AAA52593.1; -; Genomic_DNA.
DR   CCDS; CCDS12437.1; -. [P06744-1]
DR   CCDS; CCDS54246.1; -. [P06744-2]
DR   PIR; A35333; A35333.
DR   RefSeq; NP_000166.2; NM_000175.4. [P06744-1]
DR   RefSeq; NP_001171651.1; NM_001184722.1. [P06744-2]
DR   RefSeq; NP_001316838.1; NM_001329909.1. [P06744-1]
DR   RefSeq; NP_001316839.1; NM_001329910.1. [P06744-1]
DR   RefSeq; NP_001316840.1; NM_001329911.1.
DR   UniGene; Hs.466471; -.
DR   UniGene; Hs.515344; -.
DR   PDB; 1IAT; X-ray; 1.62 A; A=2-558.
DR   PDB; 1IRI; X-ray; 2.40 A; A/B/C/D=1-558.
DR   PDB; 1JIQ; X-ray; 1.90 A; A/B/C/D=1-558.
DR   PDB; 1JLH; X-ray; 2.10 A; A/B/C/D=1-558.
DR   PDB; 1NUH; X-ray; 2.51 A; A=1-558.
DR   PDBsum; 1IAT; -.
DR   PDBsum; 1IRI; -.
DR   PDBsum; 1JIQ; -.
DR   PDBsum; 1JLH; -.
DR   PDBsum; 1NUH; -.
DR   ProteinModelPortal; P06744; -.
DR   SMR; P06744; -.
DR   BioGrid; 109082; 46.
DR   IntAct; P06744; 6.
DR   MINT; MINT-4999095; -.
DR   DrugBank; DB02093; 5-Phospho-D-Arabinohydroxamic Acid.
DR   DrugBank; DB03042; 5-Phosphoarabinonic Acid.
DR   DrugBank; DB02076; 6-Phosphogluconic Acid.
DR   DrugBank; DB02007; alpha-D-glucose 6-phosphate.
DR   DrugBank; DB02548; D-glucitol 6-phosphate.
DR   DrugBank; DB03937; Erythose-4-Phosphate.
DR   DrugBank; DB04493; Fructose-6-Phosphate.
DR   DrugBank; DB03581; Glucose-6-Phosphate.
DR   iPTMnet; P06744; -.
DR   PhosphoSitePlus; P06744; -.
DR   SwissPalm; P06744; -.
DR   BioMuta; GPI; -.
DR   DMDM; 17380385; -.
DR   EPD; P06744; -.
DR   MaxQB; P06744; -.
DR   PeptideAtlas; P06744; -.
DR   PRIDE; P06744; -.
DR   TopDownProteomics; P06744-1; -. [P06744-1]
DR   TopDownProteomics; P06744-2; -. [P06744-2]
DR   DNASU; 2821; -.
DR   Ensembl; ENST00000356487; ENSP00000348877; ENSG00000105220. [P06744-1]
DR   Ensembl; ENST00000415930; ENSP00000405573; ENSG00000105220. [P06744-2]
DR   GeneID; 2821; -.
DR   KEGG; hsa:2821; -.
DR   UCSC; uc002nvg.3; human. [P06744-1]
DR   CTD; 2821; -.
DR   DisGeNET; 2821; -.
DR   GeneCards; GPI; -.
DR   HGNC; HGNC:4458; GPI.
DR   HPA; CAB018655; -.
DR   HPA; CAB040563; -.
DR   HPA; HPA024305; -.
DR   HPA; HPA052171; -.
DR   MalaCards; GPI; -.
DR   MIM; 172400; gene.
DR   MIM; 613470; phenotype.
DR   neXtProt; NX_P06744; -.
DR   OpenTargets; ENSG00000105220; -.
DR   Orphanet; 712; Hemolytic anemia due to glucophosphate isomerase deficiency.
DR   PharmGKB; PA28841; -.
DR   GeneTree; ENSGT00390000000707; -.
DR   HOGENOM; HOG000261370; -.
DR   HOVERGEN; HBG002877; -.
DR   InParanoid; P06744; -.
DR   KO; K01810; -.
DR   PhylomeDB; P06744; -.
DR   TreeFam; TF300436; -.
DR   BioCyc; MetaCyc:HS02693-MONOMER; -.
DR   BRENDA; 5.3.1.9; 2681.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P06744; -.
DR   SIGNOR; P06744; -.
DR   UniPathway; UPA00109; UER00181.
DR   ChiTaRS; GPI; human.
DR   EvolutionaryTrace; P06744; -.
DR   GeneWiki; Glucose-6-phosphate_isomerase; -.
DR   GenomeRNAi; 2821; -.
DR   PRO; PR:P06744; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105220; -.
DR   CleanEx; HS_GPI; -.
DR   ExpressionAtlas; P06744; baseline and differential.
DR   Genevisible; P06744; HS.
DR   GO; GO:0060170; C:ciliary membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0004347; F:glucose-6-phosphate isomerase activity; TAS:Reactome.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0016866; F:intramolecular transferase activity; IEA:Ensembl.
DR   GO; GO:0048029; F:monosaccharide binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0046185; P:aldehyde catabolic process; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc.
DR   GO; GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0051156; P:glucose 6-phosphate metabolic process; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0007599; P:hemostasis; TAS:ProtInc.
DR   GO; GO:0006959; P:humoral immune response; TAS:ProtInc.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:0019242; P:methylglyoxal biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IDA:CAFA.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0043278; P:response to morphine; IEA:Ensembl.
DR   GO; GO:0035994; P:response to muscle stretch; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   Gene3D; 1.10.1390.10; -; 1.
DR   HAMAP; MF_00473; G6P_isomerase; 1.
DR   InterPro; IPR001672; G6P_Isomerase.
DR   InterPro; IPR023096; G6P_Isomerase_C.
DR   InterPro; IPR018189; Phosphoglucose_isomerase_CS.
DR   PANTHER; PTHR11469; PTHR11469; 1.
DR   Pfam; PF00342; PGI; 1.
DR   PRINTS; PR00662; G6PISOMERASE.
DR   PROSITE; PS00765; P_GLUCOSE_ISOMERASE_1; 1.
DR   PROSITE; PS00174; P_GLUCOSE_ISOMERASE_2; 1.
DR   PROSITE; PS51463; P_GLUCOSE_ISOMERASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Angiogenesis;
KW   Complete proteome; Cytokine; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Gluconeogenesis; Glycolysis; Growth factor;
KW   Hereditary hemolytic anemia; Isomerase; Phosphoprotein; Polymorphism;
KW   Reference proteome; Secreted; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    558       Glucose-6-phosphate isomerase.
FT                                /FTId=PRO_0000180537.
FT   ACT_SITE    358    358       Proton donor.
FT   ACT_SITE    389    389
FT   ACT_SITE    519    519
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES      12     12       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     107    107       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     109    109       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     142    142       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     185    185       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:11004567,
FT                                ECO:0000269|PubMed:15637053}.
FT   MOD_RES     250    250       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6P6V0}.
FT   MOD_RES     454    454       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06745}.
FT   MOD_RES     454    454       N6-malonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MOD_RES     454    454       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06745}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      1       M -> MVALCSLQHLGSSDPRALPTLPTATSGQRPAKRRRK
FT                                SPAM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043475.
FT   VAR_SEQ     135    162       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043476.
FT   VARIANT       5      5       T -> I (in HA-GPID; GPI Matsumoto;
FT                                dbSNP:rs267606852).
FT                                {ECO:0000269|PubMed:8822954}.
FT                                /FTId=VAR_002516.
FT   VARIANT      20     20       H -> P (in HA-GPID; severe form with
FT                                neurological deficits; GPI Homburg;
FT                                dbSNP:rs137853586).
FT                                {ECO:0000269|PubMed:9856489}.
FT                                /FTId=VAR_002517.
FT   VARIANT      75     75       R -> G (in HA-GPID; GPI Elyria).
FT                                {ECO:0000269|PubMed:9446754}.
FT                                /FTId=VAR_002518.
FT   VARIANT      83     83       R -> W (in HA-GPID).
FT                                {ECO:0000269|PubMed:7989588}.
FT                                /FTId=VAR_002519.
FT   VARIANT     101    101       V -> M (in HA-GPID; GPI Sarcina;
FT                                dbSNP:rs757341382).
FT                                {ECO:0000269|PubMed:8822952}.
FT                                /FTId=VAR_002521.
FT   VARIANT     159    159       G -> S (in HA-GPID; dbSNP:rs137853582).
FT                                {ECO:0000269|PubMed:8499925}.
FT                                /FTId=VAR_002520.
FT   VARIANT     195    195       T -> I (in HA-GPID; GPI Bari and Mola).
FT                                {ECO:0000269|PubMed:8822952}.
FT                                /FTId=VAR_002522.
FT   VARIANT     208    208       I -> T (in dbSNP:rs8191371).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018816.
FT   VARIANT     224    224       T -> M (in HA-GPID; GPI Iwate;
FT                                dbSNP:rs61754634).
FT                                {ECO:0000269|PubMed:7989588,
FT                                ECO:0000269|PubMed:8822954}.
FT                                /FTId=VAR_002523.
FT   VARIANT     273    273       R -> H (in HA-GPID).
FT                                {ECO:0000269|PubMed:7989588}.
FT                                /FTId=VAR_002524.
FT   VARIANT     278    278       S -> L (in HA-GPID; dbSNP:rs34306618).
FT                                {ECO:0000269|PubMed:7989588}.
FT                                /FTId=VAR_002525.
FT   VARIANT     300    300       A -> P (in HA-GPID).
FT                                {ECO:0000269|PubMed:9446754}.
FT                                /FTId=VAR_002526.
FT   VARIANT     308    308       R -> H (in dbSNP:rs2230294).
FT                                /FTId=VAR_033943.
FT   VARIANT     339    339       L -> P (in HA-GPID; severe form with
FT                                neurological deficits; GPI Homburg;
FT                                dbSNP:rs137853587).
FT                                {ECO:0000269|PubMed:9856489}.
FT                                /FTId=VAR_002527.
FT   VARIANT     343    343       Q -> R (in HA-GPID; GPI Narita and
FT                                Morcone; dbSNP:rs267606851).
FT                                {ECO:0000269|PubMed:8822952,
FT                                ECO:0000269|PubMed:8822954}.
FT                                /FTId=VAR_002528.
FT   VARIANT     347    347       R -> C (in HA-GPID; GPI Mount Scopus;
FT                                dbSNP:rs758132799).
FT                                {ECO:0000269|PubMed:7989588,
FT                                ECO:0000269|PubMed:9446754}.
FT                                /FTId=VAR_002529.
FT   VARIANT     347    347       R -> H (in HA-GPID; dbSNP:rs137853583).
FT                                {ECO:0000269|PubMed:8499925}.
FT                                /FTId=VAR_002530.
FT   VARIANT     375    375       T -> R (in HA-GPID; GPI Kinki;
FT                                dbSNP:rs267606853).
FT                                {ECO:0000269|PubMed:8822954}.
FT                                /FTId=VAR_002531.
FT   VARIANT     389    389       H -> R (in HA-GPID; severe form; GPI
FT                                Calden; dbSNP:rs139382538).
FT                                {ECO:0000269|PubMed:9856489}.
FT                                /FTId=VAR_002532.
FT   VARIANT     472    472       R -> H (in HA-GPID; dbSNP:rs148811525).
FT                                {ECO:0000269|PubMed:9446754}.
FT                                /FTId=VAR_002533.
FT   VARIANT     487    487       L -> F (in HA-GPID; dbSNP:rs374583873).
FT                                {ECO:0000269|PubMed:7989588}.
FT                                /FTId=VAR_002534.
FT   VARIANT     495    495       E -> K (in HA-GPID).
FT                                {ECO:0000269|PubMed:7989588}.
FT                                /FTId=VAR_002535.
FT   VARIANT     517    517       L -> V (in HA-GPID; severe form; GPI
FT                                Calden). {ECO:0000269|PubMed:9856489}.
FT                                /FTId=VAR_002536.
FT   VARIANT     525    525       I -> T (in HA-GPID; dbSNP:rs137853584).
FT                                {ECO:0000269|PubMed:8499925,
FT                                ECO:0000269|PubMed:8822952}.
FT                                /FTId=VAR_002537.
FT   VARIANT     539    539       D -> N (in HA-GPID; GPI Fukuoka and
FT                                Kinki; dbSNP:rs137853585).
FT                                {ECO:0000269|PubMed:8822954}.
FT                                /FTId=VAR_002538.
FT   MUTAGEN     185    185       S->A: Retained full enzymatic activity.
FT                                {ECO:0000269|PubMed:15637053}.
FT   MUTAGEN     185    185       S->E: Decreased enzymatic activity.
FT                                {ECO:0000269|PubMed:15637053}.
FT   CONFLICT    158    158       G -> V (in Ref. 1; AAA36368).
FT                                {ECO:0000305}.
FT   CONFLICT    426    426       L -> V (in Ref. 2; AAF22645).
FT                                {ECO:0000305}.
FT   CONFLICT    436    436       L -> V (in Ref. 2; AAF22645).
FT                                {ECO:0000305}.
FT   HELIX         3      6       {ECO:0000244|PDB:1IAT}.
FT   HELIX         8     20       {ECO:0000244|PDB:1IAT}.
FT   HELIX        21     23       {ECO:0000244|PDB:1IAT}.
FT   HELIX        26     32       {ECO:0000244|PDB:1IAT}.
FT   HELIX        36     39       {ECO:0000244|PDB:1IAT}.
FT   STRAND       41     45       {ECO:0000244|PDB:1IAT}.
FT   STRAND       50     54       {ECO:0000244|PDB:1IAT}.
FT   STRAND       57     59       {ECO:0000244|PDB:1IAT}.
FT   HELIX        62     74       {ECO:0000244|PDB:1IAT}.
FT   HELIX        77     85       {ECO:0000244|PDB:1IAT}.
FT   TURN         92     95       {ECO:0000244|PDB:1IAT}.
FT   HELIX       100    103       {ECO:0000244|PDB:1IAT}.
FT   STRAND      116    118       {ECO:0000244|PDB:1IAT}.
FT   HELIX       119    137       {ECO:0000244|PDB:1IAT}.
FT   STRAND      151    155       {ECO:0000244|PDB:1IAT}.
FT   HELIX       158    160       {ECO:0000244|PDB:1IAT}.
FT   HELIX       162    170       {ECO:0000244|PDB:1IAT}.
FT   HELIX       172    174       {ECO:0000244|PDB:1IAT}.
FT   STRAND      180    184       {ECO:0000244|PDB:1IAT}.
FT   HELIX       189    196       {ECO:0000244|PDB:1IAT}.
FT   HELIX       201    203       {ECO:0000244|PDB:1IAT}.
FT   STRAND      204    209       {ECO:0000244|PDB:1IAT}.
FT   STRAND      211    213       {ECO:0000244|PDB:1IAT}.
FT   HELIX       216    233       {ECO:0000244|PDB:1IAT}.
FT   HELIX       236    238       {ECO:0000244|PDB:1IAT}.
FT   HELIX       239    242       {ECO:0000244|PDB:1IAT}.
FT   STRAND      243    248       {ECO:0000244|PDB:1IAT}.
FT   HELIX       250    256       {ECO:0000244|PDB:1IAT}.
FT   HELIX       260    262       {ECO:0000244|PDB:1IAT}.
FT   STRAND      263    265       {ECO:0000244|PDB:1IAT}.
FT   HELIX       272    274       {ECO:0000244|PDB:1IAT}.
FT   TURN        276    278       {ECO:0000244|PDB:1IAT}.
FT   HELIX       279    281       {ECO:0000244|PDB:1IAT}.
FT   HELIX       282    288       {ECO:0000244|PDB:1IAT}.
FT   HELIX       290    309       {ECO:0000244|PDB:1IAT}.
FT   HELIX       312    314       {ECO:0000244|PDB:1IAT}.
FT   HELIX       316    329       {ECO:0000244|PDB:1IAT}.
FT   STRAND      335    341       {ECO:0000244|PDB:1IAT}.
FT   HELIX       343    345       {ECO:0000244|PDB:1IAT}.
FT   HELIX       348    360       {ECO:0000244|PDB:1IAT}.
FT   STRAND      378    380       {ECO:0000244|PDB:1IAT}.
FT   HELIX       386    389       {ECO:0000244|PDB:1IAT}.
FT   HELIX       392    397       {ECO:0000244|PDB:1IAT}.
FT   STRAND      398    400       {ECO:0000244|PDB:1JLH}.
FT   STRAND      404    411       {ECO:0000244|PDB:1IAT}.
FT   HELIX       416    419       {ECO:0000244|PDB:1IAT}.
FT   HELIX       420    438       {ECO:0000244|PDB:1IAT}.
FT   HELIX       442    451       {ECO:0000244|PDB:1IAT}.
FT   HELIX       456    462       {ECO:0000244|PDB:1IAT}.
FT   HELIX       463    466       {ECO:0000244|PDB:1IAT}.
FT   STRAND      474    481       {ECO:0000244|PDB:1IAT}.
FT   HELIX       484    505       {ECO:0000244|PDB:1IAT}.
FT   HELIX       513    515       {ECO:0000244|PDB:1IAT}.
FT   HELIX       516    528       {ECO:0000244|PDB:1IAT}.
FT   STRAND      530    532       {ECO:0000244|PDB:1IAT}.
FT   HELIX       540    552       {ECO:0000244|PDB:1IAT}.
SQ   SEQUENCE   558 AA;  63147 MW;  7C8E95277BDC79A6 CRC64;
     MAALTRDPQF QKLQQWYREH RSELNLRRLF DANKDRFNHF SLTLNTNHGH ILVDYSKNLV
     TEDVMRMLVD LAKSRGVEAA RERMFNGEKI NYTEGRAVLH VALRNRSNTP ILVDGKDVMP
     EVNKVLDKMK SFCQRVRSGD WKGYTGKTIT DVINIGIGGS DLGPLMVTEA LKPYSSGGPR
     VWYVSNIDGT HIAKTLAQLN PESSLFIIAS KTFTTQETIT NAETAKEWFL QAAKDPSAVA
     KHFVALSTNT TKVKEFGIDP QNMFEFWDWV GGRYSLWSAI GLSIALHVGF DNFEQLLSGA
     HWMDQHFRTT PLEKNAPVLL ALLGIWYINC FGCETHAMLP YDQYLHRFAA YFQQGDMESN
     GKYITKSGTR VDHQTGPIVW GEPGTNGQHA FYQLIHQGTK MIPCDFLIPV QTQHPIRKGL
     HHKILLANFL AQTEALMRGK STEEARKELQ AAGKSPEDLE RLLPHKVFEG NRPTNSIVFT
     KLTPFMLGAL VAMYEHKIFV QGIIWDINSF DQWGVELGKQ LAKKIEPELD GSAQVTSHDA
     STNGLINFIK QQREARVQ
//
